Based on the Haemonetics Corporation stock forecast from 8 analysts, the average analyst target price for Haemonetics Corporation is USD 108.58 over the next 12 months. Haemonetics Corporation’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Haemonetics Corporation is Very Bearish, which is based on 0 positive signals and 2 negative signals. At the last closing, Haemonetics Corporation’s stock price was USD 85.43. Haemonetics Corporation’s stock price has changed by -5.86% over the past week, +14.10% over the past month and +4.21% over the last year.
No recent analyst target price found for Haemonetics Corporation
No recent average analyst rating found for Haemonetics Corporation
Company Overview Haemonetics Corporation
N/A
N/A
N/A
N/A
USD
USA
Adjusted Closing Price for Haemonetics Corporation (HAE)
Loading...
Unadjusted Closing Price for Haemonetics Corporation (HAE)
Loading...
Share Trading Volume for Haemonetics Corporation Shares
Loading...
Compare Performance of Haemonetics Corporation Shares
Frequently Asked Questions About Haemonetics Corporation (HAE) Stock
Based on ratings from 8 analysts Haemonetics Corporation's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bearish. The stock has 10 buy, sell and 2 hold ratings.
Unfortunately we do not have enough data on HAE's stock to indicate if its a good dividend stock.
Based on targets from 8 analysts, the average taret price for HAE is USD 108.58 over the next 12 months. The maximum analyst target price is USD 125 while the minimum anlayst target price is USD 85.
Unfortunately we do not have enough data on HAE's stock to indicate if its overvalued.
The last closing price of HAE's stock was USD 85.43.
Unfortunately we do not currently have any market capitalization data for HAE's stock.
Based on targets from 8 analysts, the average taret price for HAE is projected at USD 108.58 over the next 12 months.
This means that HAE's stock price may go up by +27.10% over the next 12 months.
We can't find any ETFs which contains Haemonetics Corporation's stock.
Sorry, we do not have any data on the number of employees for Haemonetics Corporation.
Sorry we do not have any infomation available on Haemonetics Corporation's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Frequently Asked Questions About Haemonetics Corporation (HAE) Stock
Based on ratings from 8 analysts Haemonetics Corporation's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bearish. The stock has 10 buy, sell and 2 hold ratings.
Unfortunately we do not have enough data on HAE's stock to indicate if its a good dividend stock.
Based on targets from 8 analysts, the average taret price for HAE is USD 108.58 over the next 12 months. The maximum analyst target price is USD 125 while the minimum anlayst target price is USD 85.
Unfortunately we do not have enough data on HAE's stock to indicate if its overvalued.
The last closing price of HAE's stock was USD 85.43.
Unfortunately we do not currently have any market capitalization data for HAE's stock.
Based on targets from 8 analysts, the average taret price for HAE is projected at USD 108.58 over the next 12 months.
This means that HAE's stock price may go up by +27.10% over the next 12 months.
We can't find any ETFs which contains Haemonetics Corporation's stock.
Sorry, we do not have any data on the number of employees for Haemonetics Corporation.
Sorry we do not have any infomation available on Haemonetics Corporation's address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for HAE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
